Views | |
---|---|
Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 65 |
January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
---|---|---|---|---|---|---|---|
Favorable therapeutic response after anti-Mesothelin antibody–drug conjugate treatment requires high expression of Mesothelin in tumor cells | 2 | 6 | 0 | 1 | 3 | 2 | 3 |
Views | |
---|---|
2020_Lazzerini_etal.pdf | 36 |